Degranulation Response in Cytotoxic Rat Lymphocytes Measured with a Novel CD107a Antibody

Amanda Sudworth1, Ke-Zheng Dai2, John T Vaage2

  • 1Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway; Department of Immunology, University of Oslo, Oslo University Hospital, Rikshospitalet, Oslo, Norway.

Frontiers in Immunology
|December 23, 2016
PubMed

Insights

Researchers developed a new antibody to measure degranulation in rat cytotoxic cells. This tool enables functional studies of natural killer (NK) cells and CD8 T cells, overcoming previous limitations in rat immunology research.

Area of Science:

  • Immunology
  • Cellular Biology

Background:

  • CD107a expression is a key indicator of cytotoxic cell degranulation and function.
  • Previous studies in rats were limited by the absence of a specific anti-rat CD107a antibody.

Purpose of the Study:

  • To develop and characterize a novel antibody for detecting rat CD107a expression.
  • To enable functional assessment of cytotoxic cells in rats.

Main Methods:

  • Generation of a hybridoma (SIM1 clone) by immunizing Armenian hamsters with CD107a-expressing cells.
  • Testing SIM1 antibody reactivity with rat natural killer (NK) cells and T cells.
  • Measuring degranulation in response to target cell stimulation and receptor crosslinking.

Main Results:

  • The SIM1 antibody specifically recognizes rat CD107a.
  • SIM1 successfully measured degranulation in NK cells under various stimulation conditions, including low effector-to-target ratios.
  • The antibody also stained activated CD8 T cells but not CD4 T cells.

Conclusions:

  • A novel anti-rat CD107a antibody (SIM1) has been developed, facilitating degranulation studies in rats.
  • This antibody is valuable for assessing the functional capacity of rat NK and CD8 T cells.
  • The findings overcome a significant hurdle in rat immunology, enabling more detailed functional analysis of cytotoxic responses.

Related Concept Videos